Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
MDT.US
id: 265
D. Minnesota
Court
On May 26, 2022, Medtronic reported financial results and disclosed that as a result of the Company’s need to improve its quality control system and its expectation that the MiniMed 780G model which management had repeatedly identified as crucial to future growth would not be approved in 2023, the Company expected revenues from its Diabetes Group to decline between 6% and 7% in the fiscal year 2023.
Back on December 15, 2021, Medtronic revealed that it had received a warning letter from the FDA regarding its Northridge, California facility. The Warning Letter followed an FDA inspection relating to the Company’s MiniMed 600 series recall, and focused on “the inadequacy of specific medical device quality system requirements . . . in the areas of risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events.”
The Warning Letter further explained that Medtronic had known about the MiniMed quality issues for several years before the Company finally initiated the recall and that it failed to appropriately respond to complaints and report safety issues.
On this news, the price of Medtronic stock declined about 6% and lost several billion of its capitalization, seriously damaging investors.
Case Status
Attorney Investigation
Alleged Offence
Mismanagement
Misleading Statements
Failure to Disclose
Negligence
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
26 May 2022
Collecting participants…

Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers imp...

    Ticker
    MDT.US
    ISIN
    IE00BTN1Y115
    CIK
    1613103
    Sector
    Healthcare
    Industry
    Medical Devices
    Country
    USA
    Address
    20 On Hatch, Dublin, Ireland, 2